Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa

J Invest Dermatol. 2020 Mar;140(3):531-536.e1. doi: 10.1016/j.jid.2019.09.009. Epub 2019 Dec 20.

Abstract

Although the role of immune dysregulation in hidradenitis suppurativa (HS) has yet to be elucidated, recent studies identified several complement abnormalities in patients with HS. The complement system serves a critical role in the modulation of immune response and regulation of cutaneous commensal bacteria. Complement is implicated in several inflammatory skin diseases including systemic lupus erythematosus, angioedema, pemphigus, bullous pemphigoid, and HS. A model of HS pathogenesis is proposed, integrating the role of commensal bacteria, cutaneous immune responses, and complement dysregulation. The role of complement in disease pathogenesis has led to the development of novel anticomplement agents and clinical trials investigating the efficacy of such treatments in HS.

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Complement Activation / drug effects
  • Complement Activation / immunology*
  • Complement Inactivating Agents / pharmacology
  • Complement Inactivating Agents / therapeutic use*
  • Complement System Proteins / immunology
  • Complement System Proteins / metabolism*
  • Hidradenitis Suppurativa / immunology*
  • Hidradenitis Suppurativa / pathology
  • Humans
  • Microbiota / drug effects
  • Microbiota / immunology*
  • Skin / immunology
  • Skin / microbiology
  • Skin / pathology
  • Treatment Outcome

Substances

  • Complement Inactivating Agents
  • Complement System Proteins